glutathione vasoactive intestinal peptide Research advances of in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells Vasoactive intestinal peptide (22-28) |
Description
These doses correspond to approximately 30, 40, and 0.5 times the recommended human daily inhalation dose (RHDID) on a mcg/m2 basis, respectively
Drinkable and liposomal formats may partially protect the molecule during digestion, improving bioavailability [1]
Moreover, the detection rates of several bacterial genera including Collinsella , Lactobacillus and Bacillus were lower than those of non-IBD control group
doi: 10.1038/s41380-023-02051-w
doi: 10.1086/520980 336 RexJHBennettJESugarAMPappasPGvan der HorstCMEdwardsJEet al
